Additional clinical benefit independent of study result or trial arm allocation to participants in multi-center randomized controlled trials.
Department of Cardiology, Galilee Medical Center, Nahariya, affiliated with the Faculty of Medicine in the Galilee, Bar Ilan University, Safed, Israel. Electronic address: shaul.atar@gmail.com.
Shaul
S
Atar
D054058:Acute Coronary Syndrome / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology; D000789:Angina, Unstable / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology; D002318:Cardiovascular Diseases / Q000401:mortality; D005260:Female; D019983:Guideline Adherence; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D008297:Male; D015337:Multicenter Studies as Topic; D000072658:Non-ST Elevated Myocardial Infarction / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology; D017063:Outcome Assessment, Health Care; D017410:Practice Guidelines as Topic; D011379:Prognosis; D011787:Quality of Health Care; D016032:Randomized Controlled Trials as Topic; D000072657:ST Elevation Myocardial Infarction / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology; D055502:Secondary Prevention
D000960:Hypolipidemic Agents; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL
Cardiovascular disease; Clinical trials; Randomized trials